Daniel L. Farkas, PhD
Founder, Chairman and CEO

Daniel L. Farkas was trained in Theoretical Physics in Romania, and holds a Ph.D. in Biophysics and Biochemistry from the Weizmann Institute in Israel, where he received a number of honors (Yashinsky Outstanding Graduate Student Prize, EMBO and UNESCO fellowships, Aharon Katchalsky-Katzir Award). He came to the United States as a Fulbright scholar (also holding a Dr. Chaim Weizmann fellowship), conducted research at UC San Diego and Univ. of Washington, Seattle, and was also a Fulbright lecturer at UC Berkeley. After junior faculty appointments in the US and at the Weizmann Institute, he settled at Carnegie Mellon University as Associate Director and then Director of the Center for Light Microscope Imaging and Biotechnology (1992-2002), a National Science and Technology Center that won the Smithsonian Award for Science in 1996. Simultaneously, at the University of Pittsburgh he was Professor Bioengineering and Pathology, Director of the BioImaging Laboratories, and held core faculty appointments in the McGowan Institute for Regenerative Medicine and the Univ. of Pittsburgh Cancer Institute. Additionally, he served (1995-2005) as Associate Director of the Pittsburgh Tissue Engineering Initiative, a regional non-profit organization, recently named the National Tissue Engineering Center. In 2002 he came, as Vice-chairman for Research in the Department of Surgery, to the Cedars-Sinai Medical Center in Los Angeles, where he was also (till July 1, 2010) Director of the Minimally Invasive Surgical Technologies Institute and Professor of Surgery and Biomedical Sciences. Currently, on the academic side, he is Research Professor in Biomedical Engineering at the Univ. of Southern California; Adjunct Professor of Robotics at Carnegie Mellon University; and Visiting Professor at the Beckman Institute, California Institute of Technology. He published 160 articles and authored/edited 18 books, is on 11 journal editorial boards, chaired 25 international conferences and had $60 million in peer-reviewed funding to support his research for which he was awarded the Automated Imaging Association Award for Scientific Application (1994) and the Sylvia Sorkin Greenfield Award from the American Association of Physicists in Medicine (2002). In 2008 he was elected President of IMLAS, an international interdisciplinary surgical society. Dr. Farkas also founded a number of successful high-tech startups, including ChromoDynamics, Inc. and TissueInformatics, Inc. He is currently founder and chairman of Biomedical Optical Imaging Corporation, EpiLumina, Inc., PhotoNanoscopy, Inc. and The Brain Window, Inc., and is actively focusing on their development. Having lived in several countries, he has 3 citizenships (including US), and is fluent in 5 languages.
[ top of page ]

Fartash Vasefi, PhD
Advisor

For more than ten years, his academic and industrial work has ranged from basic fundamental research in electrical and optical engineering to translational cancer diagnostics applications. In particular, Fartash is interested in commercially adoptable technologies that use innovative optical imaging systems, image processing algorithms, and integrated micrometer and nanometer scale optical devices in biological sensing and imaging systems. Fartash received his doctorate degree in Biomedical Engineering from Simon Fraser University, Canada. His publications include conference papers (60), journal articles (20) and U.S. patent applications (4). During the doctoral and postdoctoral trainings, he has received a number of international and Canadian awards from SPIE, Canadian Institute of Health Research, and Mathematics of Information Technology and Complex Systems institutions.

As a Research Scientist at BMOIC, Fartash manages the coordination of internal personnel, contract manufacturers, academic collaborators, software developers, and strategic partners to bring a new medical device to market under quality system requirements.
[ top of page ]

Kenneth Barton
Advisor

Mr. Kenneth Barton has over 20 years of experience as a seasoned business development professional in the technology sector, specializing in growing new companies from concept to inception. Through his creation of formal business relationships with both domestic and International business partners, Ken has grown start-up companies to over $40 million in enterprise value while driving business development as a platform to dramatically increase shareholder appreciation. These partnerships include Symantec Corporation, USPS and international government agencies and ministries. Mr. Barton has initiated agreements with ministry level organizations forming branding and joint venture relationships around the world such as the Universal Postal Union, a U.N. organization. Mr. Barton has also secured domestic communication services contracts through multi-national corporations and Federal agencies including the GAO (General Accountability Office),the United States Postal Service (USPS), AT&T, Sprint, Qwest, Accenture and other system integrators and defense contractors. Mr. Barton has a B.S. in Economics from the University of Maryland and holds a J.D.
[ top of page ]

Nicholas MacKinnon, BSc, BEd, AScT, Dip.Tech.,BME
Advisor

Nick's background includes over 25 years in development of clinical and research medical devices, working in academic research and with medical device and instrument companies. He is VP Product Development, responsible for commercializing BMOIC products for early cancer diagnosis. He has an extensive background in translating clinical research devices into commercial products from both a theoretical and practical view. Nick has a background in developing innovative tissue measurement systems, imaging systems and probes.

In the early 1990s at the BC Cancer Agency (BCCA) and spin-off company, Xillix, Nick developed an autofluorescence imaging bronchoscopy system and participated in hundreds of bronchoscopy procedures during clinical trials. In 1995 he began working on extending this technology to gastroscopy and colonoscopy clinical trials. In 1999, Nick was appointed as a Core Director, Instrumentation for an eight year multi-institutional program project investigating optical technologies for cervical cancer screening and diagnosis involving MD Anderson Cancer Center, University of Texas, Austin, BCCA and Rice University. He has supervised multiple engineers, programmers and technologists, developing imaging systems and probes that eventually were applied to about two thousand patients.

Nick is also an experienced entrepreneur with over 14 years in executive management positions. He was one of the founders of Vancouver-based LED Medical Diagnostics and one of the co-inventors of its highly successful product, the VELscope, which has now screened millions of patients for oral cancer. He was a founder of Tidal Photonics Inc and its subsidiary OneLight Corporation, as well as the principal inventor of its programmable illumination technology. Nick is an inventor on over 20 US and international patents related to optical medical devices.
[ top of page ]